Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates von Corbett, Kizzmekia S, Flynn, Barbara, Foulds, Kathryn E, Francica, Joseph R, Boyoglu-Barnum, Seyhan, Werner, Anne P, Flach, Britta, O’Connell, Sarah, Bock, Kevin W, Minai, Mahnaz, Nagata, Bianca M, Andersen, Hanne, Martinez, David R, Noe, Amy T, Douek, Naomi, Donaldson, Mitzi M, Nji, Nadesh N, Alvarado, Gabriela S, Edwards, Darin K, Flebbe, Dillon R, Lamb, Evan, Doria-Rose, Nicole A, Lin, Bob C, Louder, Mark K, O’Dell, Sijy, Schmidt, Stephen D, Phung, Emily, Chang, Lauren A, Yap, Christina, Todd, John-Paul M, Pessaint, Laurent, Van Ry, Alex, Browne, Shanai, Greenhouse, Jack, Putman-Taylor, Tammy, Strasbaugh, Amanda, Campbell, Tracey-Ann, Cook, Anthony, Dodson, Alan, Steingrebe, Katelyn, Shi, Wei, Zhang, Yi, Abiona, Olubukola M, Wang, Lingshu, Pegu, Amarendra, Yang, Eun Sung, Leung, Kwanyee, Zhou, Tongqing, Teng, I-Ting, Widge, Alicia, Gordon, Ingelise, Novik, Laura, Gillespie, Rebecca A, Loomis, Rebecca J, Moliva, Juan I, Stewart-Jones, Guillaume, Himansu, Sunny, Kong, Wing-Pui, Nason, Martha C, Morabito, Kaitlyn M, Ruckwardt, Tracy J, Ledgerwood, Julie E, Gaudinski, Martin R, Kwong, Peter D, Mascola, John R, Carfi, Andrea, Lewis, Mark G, Baric, Ralph S, McDermott, Adrian, Moore, Ian N, Sullivan, Nancy J, Roederer, Mario, Seder, Robert A, Graham, Barney S

Volltext

Use of broadly neutralizing antibodies for HIV‐1 prevention von Pegu, Amarendra, Hessell, Ann J., Mascola, John R., Haigwood, Nancy L.

Volltext

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 von Zhou, Tongqing, Wang, Lingshu, Misasi, John, Pegu, Amarendra, Zhang, Yi, Harris, Darcy R, Olia, Adam S, Talana, Chloe Adrienna, Yang, Eun Sung, Chen, Man, Choe, Misook, Shi, Wei, Teng, I-Ting, Creanga, Adrian, Jenkins, Claudia, Leung, Kwanyee, Liu, Tracy, Stancofski, Erik-Stephane D, Stephens, Tyler, Zhang, Baoshan, Tsybovsky, Yaroslav, Graham, Barney S, Mascola, John R, Sullivan, Nancy J, Kwong, Peter D

Volltext

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges von Gautam, Rajeev, Nishimura, Yoshiaki, Pegu, Amarendra, Nason, Martha C., Klein, Florian, Gazumyan, Anna, Golijanin, Jovana, Buckler-White, Alicia, Sadjadpour, Reza, Wang, Keyun, Mankoff, Zachary, Schmidt, Stephen D., Lifson, Jeffrey D., Mascola, John R., Nussenzweig, Michel C., Martin, Malcolm A.

Volltext

Broadly neutralizing antibodies target the coronavirus fusion peptide von Dacon, Cherrelle, Tucker, Courtney, Peng, Linghang, Lee, Chang-Chun D, Lin, Ting-Hui, Yuan, Meng, Cong, Yu, Wang, Lingshu, Purser, Lauren, Williams, Jazmean K, Pyo, Chul-Woo, Kosik, Ivan, Hu, Zhe, Zhao, Ming, Mohan, Divya, Cooper, Andrew J R, Peterson, Mary, Skinner, Jeff, Dixit, Saurabh, Kollins, Erin, Huzella, Louis, Perry, Donna, Byrum, Russell, Lembirik, Sanae, Drawbaugh, David, Eaton, Brett, Zhang, Yi, Yang, Eun Sung, Chen, Man, Leung, Kwanyee, Weinberg, Rona S, Pegu, Amarendra, Geraghty, Daniel E, Davidson, Edgar, Douagi, Iyadh, Moir, Susan, Yewdell, Jonathan W, Schmaljohn, Connie, Crompton, Peter D, Holbrook, Michael R, Nemazee, David, Mascola, John R, Wilson, Ian A, Tan, Joshua

Volltext

Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity von Shapiro, Mariya B., Cheever, Tracy, Malherbe, Delphine C., Pandey, Shilpi, Reed, Jason, Yang, Eun Sung, Wang, Keyun, Pegu, Amarendra, Chen, Xuejun, Siess, Don, Burke, David, Henderson, Heidi, Lewinsohn, Rebecca, Fischer, Miranda, Stanton, Jeffrey J., Axthelm, Michael K., Kahl, Christoph, Park, Byung, Lewis, Anne D., Sacha, Jonah B., Mascola, John R., Hessell, Ann J., Haigwood, Nancy L.

Volltext

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection von Ko, Sung-Youl, Pegu, Amarendra, Rudicell, Rebecca S., Yang, Zhi-yong, Joyce, M. Gordon, Chen, Xuejun, Wang, Keyun, Bao, Saran, Kraemer, Thomas D., Rath, Timo, Zeng, Ming, Schmidt, Stephen D., Todd, John-Paul, Penzak, Scott R., Saunders, Kevin O., Nason, Martha C., Haase, Ashley T., Rao, Srinivas S., Blumberg, Richard S., Mascola, John R., Nabel, Gary J.

Volltext

Improvement of antibody functionality by structure-guided paratope engraftment von Liu, Qingbo, Lai, Yen-Ting, Zhang, Peng, Louder, Mark K., Pegu, Amarendra, Rawi, Reda, Asokan, Mangaiarkarasi, Chen, Xuejun, Shen, Chen-Hsiang, Chuang, Gwo-Yu, Yang, Eun Sung, Miao, Huiyi, Wang, Yuge, Fauci, Anthony S., Kwong, Peter D., Mascola, John R., Lusso, Paolo

Volltext

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody von Asokan, Mangaiarkarasi, Dias, Joana, Liu, Cuiping, Maximova, Anna, Ernste, Keenan, Pegu, Amarendra, McKee, Krisha, Shi, Wei, Chen, Xuejun, Almasri, Cassandra, Promsote, Wanwisa, Ambrozak, David R., Gama, Lucio, Hu, Jianfei, Douek, Daniel C., Todd, John-Paul, Lifson, Jeffrey D., Fourati, Slim, Sekaly, Rafick P., Crowley, Andrew R., Ackerman, Margaret E., Ko, Sung Hee, Kilam, Divya, Boritz, Eli A., Liao, Laura E., Best, Katharine, Perelson, Alan S., Mascola, John R., Koup, Richard A.

Volltext

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption von Hsu, Denise C, Schuetz, Alexandra, Imerbsin, Rawiwan, Silsorn, Decha, Pegu, Amarendra, Inthawong, Dutsadee, Sopanaporn, Jumpol, Visudhiphan, Pornsuk, Chuenarom, Weerawan, Keawboon, Boot, Shi, Wei, Robb, Merlin L, Mascola, John R, Geleziunas, Romas, Koup, Richard A, Barouch, Dan H, Michael, Nelson L, Vasan, Sandhya

Volltext

CCR2 Signaling Restricts SARS-CoV-2 Infection von Vanderheiden, Abigail, Thomas, Jeronay, Soung, Allison L, Davis-Gardner, Meredith E, Floyd, Katharine, Jin, Fengzhi, Cowan, David A, Pellegrini, Kathryn, Shi, Pei-Yong, Grakoui, Arash, Klein, Robyn S, Bosinger, Steven E, Kohlmeier, Jacob E, Menachery, Vineet D, Suthar, Mehul S

Volltext

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs von Bolton, Diane L, Pegu, Amarendra, Wang, Keyun, McGinnis, Kathleen, Nason, Martha, Foulds, Kathryn, Letukas, Valerie, Schmidt, Stephen D, Chen, Xuejun, Todd, John Paul, Lifson, Jeffrey D, Rao, Srinivas, Michael, Nelson L, Robb, Merlin L, Mascola, John R, Koup, Richard A

Volltext

Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques von Wen, Jing, Cheever, Tracy, Wang, Lan, Wu, Di, Reed, Jason, Mascola, John, Chen, Xuejun, Liu, Cuiping, Pegu, Amarendra, Sacha, Jonah B, Lu, Yunfeng, Haigwood, Nancy L, Chen, Irvin S. Y

Volltext

Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation von Crooks, Ema T, Grimley, Samantha L, Cully, Michelle, Osawa, Keiko, Dekkers, Gillian, Saunders, Kevin, Rämisch, Sebastian, Menis, Sergey, Schief, William R, Doria-Rose, Nicole, Haynes, Barton, Murrell, Ben, Cale, Evan Mitchel, Pegu, Amarendra, Mascola, John R, Vidarsson, Gestur, Binley, James M

Volltext

Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques von Calenda, Giulia, Frank, Ines, Arrode-Brusés, Géraldine, Pegu, Amarendra, Wang, Keyun, Arthos, James, Cicala, Claudia, Rogers, Kenneth A, Shirreff, Lisa, Grasperge, Brooke, Blanchard, James L, Maldonado, Stephanie, Roberts, Kevin, Gettie, Agegnehu, Villinger, Francois, Fauci, Anthony S, Mascola, John R, Martinelli, Elena

Volltext

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life von Zhang, Baoshan, Gollapudi, Deepika, Gorman, Jason, O’Dell, Sijy, Damron, Leland F., McKee, Krisha, Asokan, Mangaiarkarasi, Yang, Eun Sung, Pegu, Amarendra, Lin, Bob C., Chao, Cara W., Chen, Xuejun, Gama, Lucio, Ivleva, Vera B., Law, William H., Liu, Cuiping, Louder, Mark K., Schmidt, Stephen D., Shen, Chen-Hsiang, Shi, Wei, Stein, Judith A., Seaman, Michael S., McDermott, Adrian B., Carlton, Kevin, Mascola, John R., Kwong, Peter D., Lei, Q. Paula, Doria-Rose, Nicole A.

Volltext

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency von Zhang, Baoshan, Gorman, Jason, Kwon, Young D, Pegu, Amarendra, Chao, Cara W, Liu, Tracy, Asokan, Mangaiarkarasi, Bender, Michael F, Bylund, Tatsiana, Damron, Leland, Gollapudi, Deepika, Lei, Paula, Li, Yile, Liu, Cuiping, Louder, Mark K, McKee, Krisha, Olia, Adam S, Rawi, Reda, Schön, Arne, Wang, Shuishu, Yang, Eun Sung, Yang, Yongping, Carlton, Kevin, Doria-Rose, Nicole A, Shapiro, Lawrence, Seaman, Michael S, Mascola, John R, Kwong, Peter D

Volltext

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention von Kwon, Young D, Asokan, Mangaiarkarasi, Gorman, Jason, Zhang, Baoshan, Liu, Qingbo, Louder, Mark K, Lin, Bob C, McKee, Krisha, Pegu, Amarendra, Verardi, Raffaello, Yang, Eun Sung, Program, Vrc Production, Carlton, Kevin, Doria-Rose, Nicole A, Lusso, Paolo, Mascola, John R, Kwong, Peter D

Volltext

Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base von Corrigan, Angela R., Duan, Hongying, Cheng, Cheng, Gonelli, Christopher A., Ou, Li, Xu, Kai, DeMouth, Megan E., Geng, Hui, Narpala, Sandeep, O’Connell, Sarah, Zhang, Baoshan, Zhou, Tongqing, Basappa, Manjula, Boyington, Jeffrey C., Chen, Steven J., O’Dell, Sijy, Pegu, Amarendra, Stephens, Tyler, Tsybovsky, Yaroslav, van Schooten, Jelle, Todd, John P., Wang, Shuishu, Doria-Rose, Nicole A., Foulds, Kathryn E., Koup, Richard A., McDermott, Adrian B., van Gils, Marit J., Kwong, Peter D., Mascola, John R.

Volltext

Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN von RAPPOCCIOLO, Giovanna, HENSLER, Heather R, JAIS, Mariel, REINHART, Todd A, PEGU, Amarendra, JENKINS, Frank J, RINALDO, Charles R

Volltext